These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


404 related items for PubMed ID: 15476576

  • 1. Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest.
    Watanabe Y, Ohshima H, Mizuno K, Sekiguchi C, Fukunaga M, Kohri K, Rittweger J, Felsenberg D, Matsumoto T, Nakamura T.
    J Bone Miner Res; 2004 Nov; 19(11):1771-8. PubMed ID: 15476576
    [Abstract] [Full Text] [Related]

  • 2. Risk of renal stone formation induced by long-term bed rest could be decreased by premedication with bisphosphonate and increased by resistive exercise.
    Okada A, Ohshima H, Itoh Y, Yasui T, Tozawa K, Kohri K.
    Int J Urol; 2008 Jul; 15(7):630-5. PubMed ID: 18479353
    [Abstract] [Full Text] [Related]

  • 3. Muscle atrophy and bone loss after 90 days' bed rest and the effects of flywheel resistive exercise and pamidronate: results from the LTBR study.
    Rittweger J, Frost HM, Schiessl H, Ohshima H, Alkner B, Tesch P, Felsenberg D.
    Bone; 2005 Jun; 36(6):1019-29. PubMed ID: 15811637
    [Abstract] [Full Text] [Related]

  • 4. Renal stone risk in a simulated microgravity environment: impact of treadmill exercise with lower body negative pressure.
    Monga M, Macias B, Groppo E, Kostelec M, Hargens A.
    J Urol; 2006 Jul; 176(1):127-31. PubMed ID: 16753386
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of treadmill exercise in a lower body negative pressure chamber as a countermeasure for weightlessness-induced bone loss: a bed rest study with identical twins.
    Smith SM, Davis-Street JE, Fesperman JV, Calkins DS, Bawa M, Macias BR, Meyer RS, Hargens AR.
    J Bone Miner Res; 2003 Dec; 18(12):2223-30. PubMed ID: 14672358
    [Abstract] [Full Text] [Related]

  • 6. WISE-2005: supine treadmill exercise within lower body negative pressure and flywheel resistive exercise as a countermeasure to bed rest-induced bone loss in women during 60-day simulated microgravity.
    Smith SM, Zwart SR, Heer M, Lee SM, Baecker N, Meuche S, Macias BR, Shackelford LC, Schneider S, Hargens AR.
    Bone; 2008 Mar; 42(3):572-81. PubMed ID: 18249055
    [Abstract] [Full Text] [Related]

  • 7. [Kidney stone formation during space flight and long-term bed rest].
    Okada A, Ichikawa J, Tozawa K.
    Clin Calcium; 2011 Oct; 21(10):1505-10. PubMed ID: 21960236
    [Abstract] [Full Text] [Related]

  • 8. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y, Jamart J, Esselinckx W, Devogelaer JP.
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [Abstract] [Full Text] [Related]

  • 9. The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects.
    Zerwekh JE, Ruml LA, Gottschalk F, Pak CY.
    J Bone Miner Res; 1998 Oct; 13(10):1594-601. PubMed ID: 9783548
    [Abstract] [Full Text] [Related]

  • 10. Changes in bone turnover markers during 14-day 6 degrees head-down bed rest.
    Kim H, Iwasaki K, Miyake T, Shiozawa T, Nozaki S, Yajima K.
    J Bone Miner Metab; 2003 Oct; 21(5):311-5. PubMed ID: 12928833
    [Abstract] [Full Text] [Related]

  • 11. Recovery of muscle atrophy and bone loss from 90 days bed rest: results from a one-year follow-up.
    Rittweger J, Felsenberg D.
    Bone; 2009 Feb; 44(2):214-24. PubMed ID: 19022418
    [Abstract] [Full Text] [Related]

  • 12. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
    Dodidou P, Bruckner T, Hosch S, Haass M, Klar E, Sauer P, Ziegler R, Leidig-Bruckner G.
    Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
    [Abstract] [Full Text] [Related]

  • 13. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
    Monegal A, Guañabens N, Suárez MJ, Suárez F, Clemente G, García-González M, De la Mata M, Serrano T, Casafont F, Tome S, Barrios C, Navasa M.
    Transpl Int; 2009 Feb; 22(2):198-206. PubMed ID: 18796000
    [Abstract] [Full Text] [Related]

  • 14. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD.
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of bone resorption by pamidronate cannot restore normal gain in cortical bone mass and strength in tail-suspended rapidly growing rats.
    Kodama Y, Nakayama K, Fuse H, Fukumoto S, Kawahara H, Takahashi H, Kurokawa T, Sekiguchi C, Nakamura T, Matsumoto T.
    J Bone Miner Res; 1997 Jul; 12(7):1058-67. PubMed ID: 9200005
    [Abstract] [Full Text] [Related]

  • 16. Changes in markers of bone formation and resorption in a bed rest model of weightlessness.
    Lueken SA, Arnaud SB, Taylor AK, Baylink DJ.
    J Bone Miner Res; 1993 Dec; 8(12):1433-8. PubMed ID: 8304043
    [Abstract] [Full Text] [Related]

  • 17. Effect of bed rest immobilization on metabolic turnover of bone and bone mineral density.
    Fukuoka H, Nishimura Y, Haruna M, Suzuki Y, Oyama K, Igawa S, Sekiguchi C, Murai T, Shigematsu T, Sudoh M, Akimura H, Gunji A.
    J Gravit Physiol; 1997 Jan; 4(1):S75-81. PubMed ID: 11541182
    [Abstract] [Full Text] [Related]

  • 18. Effect of bed rest during pregnancy on bone turnover markers in pregnant and postpartum women.
    Kaji T, Yasui T, Suto M, Mitani R, Morine M, Uemura H, Maeda K, Irahara M.
    Bone; 2007 Apr; 40(4):1088-94. PubMed ID: 17229597
    [Abstract] [Full Text] [Related]

  • 19. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB.
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [Abstract] [Full Text] [Related]

  • 20. Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases.
    Cremers SC, Papapoulos SE, Gelderblom H, Seynaeve C, den Hartigh J, Vermeij P, van der Rijt CC, van Zuylen L.
    J Bone Miner Res; 2005 Sep; 20(9):1543-7. PubMed ID: 16059626
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.